Birgitte Volck Net Worth

Birgitte Volck biography

Dr. Birgitte Volck, M.D. Ph.D., serves as President - Research & Development of the Company. From June 2016 to August 2018, she served as senior vice president and head of research and development, Rare Disease at GlaxoSmithKline plc. Prior to joining GlaxoSmithKline plc, she served as chief medical officer and senior vice president, development at Swedish Orphan Biovitrum (SOBI), a biopharmaceutical company, from 2012 to 2016. Dr. Volck received her M.D. and Ph.D. degrees from Copenhagen University, Denmark.

What is the salary of Birgitte Volck?

As the President - Research & Development of AvroBio Inc, the total compensation of Birgitte Volck at AvroBio Inc is $4,384,270. There are no executives at AvroBio Inc getting paid more.

How old is Birgitte Volck?

Birgitte Volck is 57, he's been the President - Research & Development of AvroBio Inc since 2018. There are 12 older and 8 younger executives at AvroBio Inc. The oldest executive at AvroBio Inc is Christopher Paige, 67, who is the Independent Director.

What's Birgitte Volck's mailing address?

Birgitte's mailing address filed with the SEC is 203 REDWOOD SHORES PKWY, STE 500, , REDWOOD CITY, CA, 94065.

Insiders trading at AvroBio Inc

Over the last 6 years, insiders at AvroBio Inc have traded over $3,066,308 worth of AvroBio Inc stock and bought 2,395,057 units worth $31,037,133 . The most active insiders traders include Braden Michael Leonard, Bruce Booth, eVenture Fund X, L.P.Atlas V.... On average, AvroBio Inc executives and independent directors trade stock every 102 days with the average trade being worth of $206,675. The most recent stock trade was executed by Braden Michael Leonard on 13 May 2024, trading 766,635 units of AVRO stock currently worth $973,626.

What does AvroBio Inc do?

clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.

AvroBio Inc executives and stock owners

AvroBio Inc executives and other stock owners filed with the SEC include:

• Birgitte Volck,
  President - Research & Development
• Erik Ostrowski,
  Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, Treasurer
• Geoff MacKay,
  President, Chief Executive Officer, Director
• Steven Avruch,
  Secretary, Chief Legal Officer
• Geoff MacKay BSc,
  Co- Founder, Pres, CEO & Director
• Geoff MacKay,
  Co- Founder, Pres, CEO & Director
• Erik Ostrowski M.B.A.,
  CFO & Treasurer
• Steven N. Avruch J.D.,
  Chief Legal Officer & Sec.
• Philip Vickers,
  Independent Director
• Bruce Booth,
  Independent Chairman of the Board
• Christopher Paige,
  Independent Director
• Phillip Donenberg,
  Independent Director
• Annalisa Jenkins,
  Independent Director
• Ian Clark,
  Independent Director
• Gail Farfel,
  Director
• Kim Raineri,
  Chief Manufacturing and Technology Officer
• Chris Brinzey,
  IR Contact Officer
• Deanna Petersen,
  Chief Business Officer
• Dr. Essra Ridha FFPM, M.D.,
  Chief Medical Officer
• Andreas Kouri,
  Sr. VP of Global Supply Chain & External Manufacturing
• Azadeh Golipour Ph.D.,
  Chief Technology Officer
• Deanna M. Petersen MBA,
  Chief Bus. Officer
• Dr. Christopher Mason FMEDSCI, FRCS, M.D., Ph.D.,
  Chief Scientific Officer
• Dr. Christopher Mason FMEDSCI, M.D., Ph.D., FRCS,
  Chief Scientific Officer
• Deanna M. Petersen M.B.A., MBA,
  Chief Bus. Officer
• Georgette Verdin,
  Chief HR Officer
• Monique Da Silva,
  Sr. VP of Corp. Communications
• Dr. Christopher Mason,
  Chief Scientific Officer
• Kim Raineri M.B.A.,
  Chief Manufacturing & Technology Officer
• Matthew Arnold,
  Head of Operations
• Jeffrey Medin Ph.D.,
  Scientific Founder
• Venture Fund X, L.P.Atlas V...,
  
• Lifesciences Iii, L.P.Claru...,
  
• Scott Requadt,
  Director
• Vi, Llcsv Life Sciences Fun...,
  
• Katina Dorton,
  Chief Financial Officer
• Nerissa Kreher,
  Chief Medical Officer
• Venture Associates X, L.P. ...,
  10% owner
• Lifesciences Iii, L.P.Claru...,
  
• Diana Escolar,
  Chief Medical Officer
• Christopher Mason,
  Chief Scientific Officer
• Essra Ridha,
  Chief Medical Officer
• Azadeh Golipour,
  Chief Technology Officer
• Braden Michael Leonard,